Skip to main content
Premium Trial:

Request an Annual Quote

ARK-Genomics Awarded $1.8M to Support Sequencing Services

NEW YORK (GenomeWeb News) – The UK government has awarded £1.1 million ($1.8 million) to the Roslin Institute's ARK-Genomics Centre for Comparative and Functional Genomics to conduct large-scale genome sequencing-based studies of livestock and other related species.

The funding from the Biotechnology and Biological Sciences Research Council will support ARK-Genomics' investments in new DNA sequencing technologies and increase its automation capabilities, BBSRC said on Wednesday.

The lab provides a range of genomics research services including DNA sequencing, gene expression analysis using sequencing and microarrays, high-throughput genotyping, and data collection and analysis.

The sequencing services the center provides use the Illumina HiSeq 2000/2500 for next-generation sequencing and the ABI 3730 for Sanger sequencing. It also offers all of the commercially available microarray tools from Affymetrix, Illumina, Agilent, and NimbleGen.

Roslin Institute Director David Hume said in a statement that the ARK-Genomics lab has established "key strategic alliances" with China's BGI and the National Institute of Animal Biotechnology in Hyderabad, India, and that the funding will help support these and other partnerships.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.